145 related articles for article (PubMed ID: 23584292)
1. Intraventricular chemotherapy for leptomeningeal carcinomatosis from lung cancer: a feasible and beneficial treatment option?
Christoph DC; Reckamp KL
J Thorac Oncol; 2013 May; 8(5):523-4. PubMed ID: 23584292
[No Abstract] [Full Text] [Related]
2. Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer.
Gwak HS; Joo J; Kim S; Yoo H; Shin SH; Han JY; Kim HT; Lee JS; Lee SH
J Thorac Oncol; 2013 May; 8(5):599-605. PubMed ID: 23422833
[TBL] [Abstract][Full Text] [Related]
3. An unexpected response to second line EGFR inhibitor in relapsing leptomeningeal carcinomatosis from lung adenocarcinoma raises questions on differential mechanisms of action of these agents.
Ghosn M; Assi T; El Rassy E; Moussa T; Kattan J
Bull Cancer; 2017 Apr; 104(4):385-387. PubMed ID: 28131317
[No Abstract] [Full Text] [Related]
4. Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era.
Park JH; Kim YJ; Lee JO; Lee KW; Kim JH; Bang SM; Chung JH; Kim JS; Lee JS
Lung Cancer; 2012 Jun; 76(3):387-92. PubMed ID: 22186628
[TBL] [Abstract][Full Text] [Related]
5. Leptomeningeal carcinomatosis in non-small cell lung cancer patients: A continuing challenge in the personalized treatment era.
Remon J; Le Rhun E; Besse B
Cancer Treat Rev; 2017 Feb; 53():128-137. PubMed ID: 28110254
[TBL] [Abstract][Full Text] [Related]
6. Four-Year Lasting Sustained Complete Response After Nivolumab in a Patient With Non-Small-Cell Lung Cancer and Confirmed Leptomeningeal Carcinomatosis: Changing the Paradigm.
Bover M; Yarza R; Docampo LI
Clin Lung Cancer; 2020 Jan; 21(1):e1-e5. PubMed ID: 31601524
[No Abstract] [Full Text] [Related]
7. ALK inhibitor crizotinib combined with intrathecal methotrexate treatment for non-small cell lung cancer with leptomeningeal carcinomatosis.
Ahn HK; Han B; Lee SJ; Lim T; Sun JM; Ahn JS; Ahn MJ; Park K
Lung Cancer; 2012 May; 76(2):253-4. PubMed ID: 22385925
[TBL] [Abstract][Full Text] [Related]
8. Intra-cranial efficacy of brigatinib in an ALK-positive non-small cell lung cancer patient presenting leptomeningeal carcinomatosis.
Gaye E; Geier M; Bore P; Guilloïque M; Lucia F; Quéré G; Gouva S; Robinet G; Descourt R
Lung Cancer; 2019 Jul; 133():1-3. PubMed ID: 31200813
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of bevacizumab and erlotinib combination for leptomeningeal carcinomatosis after failure of erlotinib.
Ariyasu R; Horiike A; Koyama J; Saiki M; Sonoda T; Kawashima Y; Takano N; Oguri T; Nishikawa S; Kitazono S; Yanagitani N; Ohyanagi F; Nishio M
Anticancer Drugs; 2017 Jun; 28(5):565-567. PubMed ID: 28225456
[TBL] [Abstract][Full Text] [Related]
10. Intracranial Response to Anti-Programmed Death 1 Therapy in a Patient with Metastatic Non-Small Cell Lung Cancer with Leptomeningeal Carcinomatosis.
Kamath SD; Kumthekar PU; Kruser TJ; Mohindra NA
Oncologist; 2018 Dec; 23(12):e159-e161. PubMed ID: 30072392
[TBL] [Abstract][Full Text] [Related]
11. Prolonged overall survival of patients with leptomeningeal carcinomatosis from nonsmall cell lung cancer.
Ju Y; Sun S; Wang J; Jiao S
J Cancer Res Ther; 2016 Oct; 12(Supplement):126-129. PubMed ID: 27721269
[TBL] [Abstract][Full Text] [Related]
12. Recovery from carcinomatous meningitis by erlotinib.
Ohara G; Kagohashi K; Kurishima K; Kawaguchi M; Nakayama H; Satoh H
Onkologie; 2011; 34(7):394-5. PubMed ID: 21734429
[No Abstract] [Full Text] [Related]
13. Clinical and Radiographic Response of Leptomeningeal and Brain Metastases to Encorafenib and Binimetinib in a Patient With BRAF V600E-Mutated Lung Adenocarcinoma.
McLoughlin EM; Fadul CE; Patel SH; Hall RD; Gentzler RD
J Thorac Oncol; 2019 Dec; 14(12):e269-e271. PubMed ID: 31757377
[No Abstract] [Full Text] [Related]
14. First case report of intrathecal panitumumab for treatment of meningeal carcinomatousis in an EGFR mutant lung adenocarcinoma patient.
Hollebecque A; Levy A; Broutin S; Lemare F; Gazzah A; Desmaris R; Chenailler C; Elbaum M; Besse B; Paci A; Soria JC
Lung Cancer; 2013 Apr; 80(1):113-4. PubMed ID: 23352031
[No Abstract] [Full Text] [Related]
15. The central nervous system as a sanctuary site in ALK-positive non-small-cell lung cancer.
Gainor JF; Ou SH; Logan J; Borges LF; Shaw AT
J Thorac Oncol; 2013 Dec; 8(12):1570-3. PubMed ID: 24389440
[TBL] [Abstract][Full Text] [Related]
16. LDK378 compassionate use for treating carcinomatous meningitis in an ALK translocated non-small-cell lung cancer.
Arrondeau J; Ammari S; Besse B; Soria JC
J Thorac Oncol; 2014 Aug; 9(8):e62-3. PubMed ID: 25157781
[No Abstract] [Full Text] [Related]
17. Leptomeningeal carcinomatosis of gastric adenocarcinoma.
Bulut G; Erden A; Karaca B; Göker E
Turk J Gastroenterol; 2011; 22(2):195-8. PubMed ID: 21796558
[TBL] [Abstract][Full Text] [Related]
18. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis].
Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S
Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431
[TBL] [Abstract][Full Text] [Related]
19. Leptomeningeal Carcinomatosis in Esophageal Cancer: Case Report and Review of Literature.
Aulakh AS; Buttar A; Piperdi B
J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S84-8. PubMed ID: 22038668
[No Abstract] [Full Text] [Related]
20. Remarkable response to dacomitinib in a patient with leptomeningeal carcinomatosis due to EGFR-mutant non-small cell lung cancer.
Mizusaki S; Otsubo K; Ninomiya T; Arimura H; Tsuchiya-Kawano Y; Inoue K
Thorac Cancer; 2021 Jan; 12(1):114-116. PubMed ID: 33112047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
